PRESS RELEASE
26 January 2026

[Webinar] Canadian Trademark Law 2025: A Year In Review

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
Our presenters Toba Cooper, Karl Racine, Jennie Yum and Kwan T. Loh will deliver a roundup of Canadian trademark law, highlighting some of the most important new cases and practice directions from 2025.
Canada

Our presenters Toba Cooper, Karl Racine, Jennie Yum and Kwan T. Loh will deliver a roundup of Canadian trademark law, highlighting some of the most important new cases and practice directions from 2025. These are the key cases and legal developments that brand owners ought to know.

Register for the webinar

Can’t attend the live webinar? Register your details and a recording will be sent to you after the webinar.

Who should attend:

  • brand owners, their marketing teams and in-house counsel
  • business owners and entrepreneurs
  • legal professionals, including IP practitioners

Speakers:

  • Toba Cooper: Toba’s practice focuses on trademark acquisition and brand management, copyright strategy and advisory work, copyright and trademark dispute resolution, litigation, licensing and transactions.
  • Karl Racine: Karl’s practice encompasses all aspects of Canadian trademark law, including trademark clearance and prosecution, contentious proceedings before the Trademarks Opposition Board, and enforcement and litigation.
  • Jennie Yum: Jennie has a broad trademark practice encompassing prosecution, advisory and opinion work, portfolio management, and enforcement of rights before the Trademarks Opposition Board and Federal Court.
  • Kwan T. Loh (Moderator): Kwan handles a wide range of matters across the trademark life cycle, including prosecution, contentious matters, and advising on trademark litigation before Canadian courts.

Looking for CPD/CLE-eligible learning?

This webinar may be eligible for Continuing Professional Development (CPD) or Continuing Legal Education (CLE) credit, subject to the requirements of your governing body.

  • LSO: This program contains 1 hour of Substantive content.
  • LSBC: This program contains 1 hour of accredited content.
  • Barreau du Québec: This program is eligible up to 1 hour in Québec.

Subscribe to be the first to receive updates on our webinars and other thought leadership content, sent straight to your inbox.

Please note that this webinar is presented in English only, with French captions available during the live session. Presentation slides will be available in both languages after the webinar.

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More